Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

LLY

Eli Lilly (LLY)

Eli Lilly and Co
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:LLY
일자시간출처헤드라인심볼기업
2024/06/0121:00PR Newswire (US)Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual MeetingNYSE:LLYEli Lilly and Co
2024/06/0103:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/3105:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/3005:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2919:00PR Newswire (US)Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseasesNYSE:LLYEli Lilly and Co
2024/05/2905:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2823:00PR Newswire (US)Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:LLYEli Lilly and Co
2024/05/2820:37IH Market NewsiPhone Sales Skyrocket in China, Nvidia Surges in Pre-Market Following xAI Fundraising, and More NewsNYSE:LLYEli Lilly and Co
2024/05/2505:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2504:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/2422:30PR Newswire (US)Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline MedicinesNYSE:LLYEli Lilly and Co
2024/05/2406:00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNYSE:LLYEli Lilly and Co
2024/05/2405:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2305:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2205:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/05/2204:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/05/2121:00PR Newswire (US)More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failureNYSE:LLYEli Lilly and Co
2024/05/2120:18IH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:LLYEli Lilly and Co
2024/05/1619:45PR Newswire (US)With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily InsulinNYSE:LLYEli Lilly and Co
2024/05/1521:00PR Newswire (US)Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance OfficerNYSE:LLYEli Lilly and Co
2024/05/1005:34Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
2024/05/0700:32PR Newswire (US)Lilly Declares Second-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
2024/04/3022:07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
2024/04/3020:59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
2024/04/3020:55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
2024/04/3019:45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
 검색 관련기사 보기:NYSE:LLY